Orthocon, Inc. – Trademark Portfolio
Entity Type: 03
Orthocon, Inc. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include AHBP, ABYRX, HEMASORB, HEMA SORB, and HEMASORB APPLY. The owner is based in Irvington, NY.
1 Bridge Street, Suite 121
Irvington, NY 10533
Showing of trademarks Trademarks
Trademark Classifications
Orthocon, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Orthocon, Inc. have?
Orthocon, Inc. has 21 U.S. trademarks filed with the USPTO. Of these, 6 registered, 9 abandoned, 6 cancelled.
What trademark classes does Orthocon, Inc. file in?
Orthocon, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Orthocon, Inc.'s most well-known trademarks?
Orthocon, Inc.'s registered trademark portfolio includes well-known marks such as AHBP, ABYRX, HEMASORB, HEMA SORB, and HEMASORB APPLY. These are among 6 currently registered trademarks in the portfolio.
What is Orthocon, Inc.'s trademark registration success rate?
Orthocon, Inc. has a 29% trademark registration rate, with 6 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.